ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N02CD02 | BioTech | Galcanezumab - 100mg/ml | 10312/945 | 167319/1 | EMGALITY | 100mg/ml | 3 | Injectable suspension | SC | Droguerie de l'Union | Eli Lilly and Company | USA | 129,435,879 L.L | 2.44 | E2 | Eli Lilly and Company | USA | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N02CD02 | BioTech | Galcanezumab - 100mg/ml | 10312 | 167319/1 | EMGALITY | 100mg/ml | 3 | Injectable suspension | SC | Droguerie de l'Union | Eli Lilly and Company | USA | 2,123,063 L.L | 2.44 | E2 | Eli Lilly and Company | USA | 2/5/2024 |